Pernille Gro Thrane

Per-patient prevalence of high-risk vulnerable plaques was comparable in STEMI vs NSTEMI, as was the overall long-term incidence of non-culprit lesion-related & all MACE. @MichaelMaeng1 @GroThrane @DavidErlinge @GreggWStone @FrobertOle @ziadalinyc ahajournals.org/doi/10.1161/CI…

In PROSPECT II, elevated TC, LDL-C, & non-HDL-C were strongly associated w/ pancoronary atherosclerosis & lipid deposition, whereas elevated Lp(a) was strongly associated w/ the presence of focal vulnerable plaques. Get more details: bit.ly/43lbEMP #JACC @JACCJournals

📖In over 215,000 pts from the #SCAAR & #WDHR registry, smoking was associated w progressive #CAD in #RCA, & smokers were more likely to receive #PCI vs RCA than #LAD when presenting with #STEMI 💡 Read more: ➡️doi.org/10.1016/j.jsca… @FrobertOle @GroThrane @GreggWStone @moman_am

Excited to share our findings on 10-year mortality after STEMI, now in @JACCJournals 👉STEMI patients surviving the first 90 days have only mildly elevated mortality compared to a matched general population. doi.org/10.1016/j.jacc… @MichaelMaeng1 #STEMI #cardiotwitter

Over the past decade, proportion of women authors in major CV journals remained low. Call to action is needed to increase equitable opportunities to promote women bit.ly/3Xj9I4X #JACC #ACCWIC #WomenInCardiology @ridhimagoel547 @Drroxmehran @DeeDeeWangMD @pamelasdouglas

This study evaluated the safety and efficacy of single antiplatelet therapy (SAPT) after left atrial appendage occlusion (LAAO) with Amplatzer devices in a cohort of 431 high bleeding risk patients. At 6 months, a significant portion of patients had discontinued antithrombotic therapy, yet the incidence of device-related thrombosis (DRT) was low at 1.5%. The 1-year ischaemic stroke rate was 2.2%, with rates of major bleeding and cardiovascular death at 5.9% and 2.9%, respectively. These findings suggest that SAPT is an effective postprocedural strategy for LAAO, efficiently balancing the prevention of DRT against the risk of bleeding. ow.ly/RMoE50QPptl Read also the Editorial by Mohamad Alkhouli eurointervention.pcronline.com/article/naviga…

🌍Real-world implications of #SELECT trial. 31% of patients with #MI are SELECT-eligible to treatment with semaglutide. Number needed to treat of 49 patients to prevent one MACE. shorturl.at/movAK #Obesity #Cardiotwitter @JACCJournals @AUHdk @AarhusUni @MaleneKHansen

🫀New publication in @JACCJournals by @CGyldenkerne et al. 👩‍🎓 Young patients with newly diagnosed #type2diabetes have the highest relative risk of #CVD 📷 Indicate an unmet need for optimized prophylactic treatment! @MichaelMaeng1 @dr_rwt link: jacc.org/doi/abs/10.101…

🎓In 43,758 individuals, @TanjaCharlotteF et al found that weight gain was associated with higher risk of AF compared to stable weight! 🔦highlighting the importance of weight management for primary prevention of AF. link: academic.oup.com/eurjpc/advance… #Cardiotwitter #Epeeps

👩‍🎓New publication in @JACCJournals 🧐Is STEMI mortality still declining? 💔Substantial reduction in 1-year mortality after pPCI-treated #STEMI from 2003 to 2018. Largest drop within 30 days, suggesting early optimization @GroThrane @MichaelMaeng1 @AUHdk rb.gy/0rg0y

Patienter med akut blodprop i hjertet, der overlever de første 90 dage, har ingen overdødelighed sammenlignet med den øvrige befolkning, viser dansk undersøgelse præsenteret på #ESCCongress2023 #sundpol buff.ly/47TncqM

@h_evald @NielsRHolm @omeedneghabat

The BMJ wants to publish the gold not the mould, the frankincense not the makes-no-sense, and the myrrh not the urrgghh. This list of 12 statistical issues routinely encountered during peer review aims to help authors of future submissions #ChristmasBMJ bmj.com/content/379/bm…

In this episode of @edecmo podcast, @MSivagowry talks about how #eCPR is performed at @AUHdk 🫀🚑🏥 Listen to the podcast here 👇🏻 bit.ly/3r06jqq

Bleeding 🩸 on dual antiplatelet therapy (DAPT) after PCI in pt’s with chronic coronary syndrome was associated with increased risk of death and rebleeding after nine years in this study presented by @GroThrane #ESCCongress 👇🏻

At #ESCCongress @KrisWarnakula just presented a large study examining wether diabetes remains a cardiovascular risk equivalent to #CHD @escardio #ESC2022 Watch this clip for the main results 👇🏻

A HUGE congratulations to Steen Dalby Kristensen for being awarded the #ESC President’s Award - what a great achievement #esccongress2022 @escardio @cardio_dk 🏆🎖🫀

Also read the linked Comment by Ibrahim Akin & Christoph A. Nienaber "Ticagrelor after Acute Coronary Syndrome: One For All or Part of Personalized Medicine?" thelancet.com/journals/lanep…

Ticagrelor was introduced in Denmark in 2011 for patients with acute coronary syndrome (ACS). This study assessed the effectiveness & safety of ticagrelor implementation in ACS patients undergoing percutaneous coronary intervention 👇🏼 tinyurl.com/mr3u5388

PhD student @GroThrane presented her study on #Ticagrelor implementation in PCI-treated #ACS patients at #ESCCongress 💊 Watch on demand 👉 cyim.page.link/JCHv @escardio #CardioTwitter